Connect to other sites within the UBM Medica Network
Lung Cancer Screening: 3 Questions You Were Afraid to Ask
I was “foggy” on when and how to apply screens for lung cancer with low-dose CT, but a perfect model for a 3-question template provided answers.
CMS Issues Final LDCT Coverage Decision
CMS released their final decision for lung cancer screening with low-dose CT.
Lung Cancer and Diabetes: A Complex Affair
A new study clarifies the link between metformin and lung cancer. Perhaps not surprisingly, a smoking habit (or lack of it) substantially affects risk.
Data Backs CT Lung Screening in More High-Risk Patients
NCCN Group 2 high-risk patients to benefit from CT lung screening, study says.
LDCT for Lung Cancer Screening: The Effect of False-Positives
Patients who underwent low-dose CT for lung cancer screening and received false-positives benefited from counseling.
What Really Works for Tough-to-Treat NSCLC?
Epidermal growth factor receptor tyrosine kinase inhibitors may not be the best option for some patients with nonsmall cell lung cancer, but an ALK inhibitor, crizotinib, proves a winner.
Phase III Immunotherapy Lung Cancer Trial Stopped Early
GlaxoSmithKline has stopped a phase III trial of a novel lung cancer immunotherapeutic agent, after determining that it may not be possible to identify which genetic subgroups may benefit from the treatment.
By clicking Accept, you agree to become a member of the UBM Medica Community.